Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Cancer Epidemiol. Biomarkers Prev. · Oct 2014
Clinical TrialReduced nicotine cigarettes: smoking behavior and biomarkers of exposure among smokers not intending to quit.
The U.S. FDA has the authority to limit the nicotine content of cigarettes; however, there are concerns that reduced nicotine cigarettes will be smoked more intensely and, therefore, will increase exposure to toxic chemicals in smoke. This study examined changes in consumer behavior and exposure in response to cigarettes with substantially reduced nicotine content. ⋯ The findings add to the evidence base on reduced nicotine content cigarettes and have the potential to inform FDA policy on nicotine levels.